PATENT CLAIM ANALYSIS

Application Number: 16129118
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "180100"]

Abstract:
The invention provides an immunoconjugate comprising an antibody construct which includes an antigen binding domain and an Fc domain, an adjuvant moiety, and a linker, wherein each adjuvant moiety is covalently bonded to the antibody via the linker which comprises an ethylene glycol group or glycine residue. Methods for treating cancer with the immunoconjugates of the invention are also described.

Claim (Index 29):
The immunoconjugate of  claim 14 , wherein a is an integer from 6 to 12.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 97.0
- Lexical Diversity: 1.41304
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12940435', '15349964', '14734957', '11978122', '13973669']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7001505359947032
- 35 USC 102 Novelty (BERT): 0.4876298539016739
- Combined Prediction Score: 0.6788984677854003
- Mean Citation Score: 175.21555200000003
- Max Citation Score: 178.13055
- Similarity Product: 121.31300854041876

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test